183 related articles for article (PubMed ID: 36675234)
1. Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens.
Yamanaka S; Suzuki S; Ito H; Sivasundaram K; Hanamura I; Okubo I; Yoshikawa K; Ono S; Takahara T; Satou A; Tsuzuki T; Ueda R; Ogawa T; Fujimoto Y
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675234
[TBL] [Abstract][Full Text] [Related]
2. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
[TBL] [Abstract][Full Text] [Related]
3. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.
Okumura Y; Nakano S; Murase T; Ueda K; Kawakita D; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
Cancer Sci; 2020 Nov; 111(11):4195-4204. PubMed ID: 32860299
[TBL] [Abstract][Full Text] [Related]
5. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells.
Chen Z; Lin S; Li JL; Ni W; Guo R; Lu J; Kaye FJ; Wu L
Oncogene; 2018 Apr; 37(14):1885-1895. PubMed ID: 29353885
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
[TBL] [Abstract][Full Text] [Related]
7. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
[TBL] [Abstract][Full Text] [Related]
8. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
[TBL] [Abstract][Full Text] [Related]
9. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion.
Lennerz JK; Perry A; Mills JC; Huettner PC; Pfeifer JD
Am J Surg Pathol; 2009 Jun; 33(6):835-43. PubMed ID: 19092631
[TBL] [Abstract][Full Text] [Related]
10. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells.
Chen J; Li JL; Chen Z; Griffin JD; Wu L
BMC Cancer; 2015 Oct; 15():803. PubMed ID: 26503699
[TBL] [Abstract][Full Text] [Related]
12. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions.
Anzick SL; Chen WD; Park Y; Meltzer P; Bell D; El-Naggar AK; Kaye FJ
Genes Chromosomes Cancer; 2010 Jan; 49(1):59-69. PubMed ID: 19827123
[TBL] [Abstract][Full Text] [Related]
13. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma.
Saade RE; Bell D; Garcia J; Roberts D; Weber R
JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):234-40. PubMed ID: 26796488
[TBL] [Abstract][Full Text] [Related]
14. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.
Ni W; Chen Z; Zhou X; Yang R; Yu M; Lu J; Kaye FJ; Wu L
Signal Transduct Target Ther; 2021 Jan; 6(1):27. PubMed ID: 33473104
[TBL] [Abstract][Full Text] [Related]
15. Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
Nakano S; Okumura Y; Murase T; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Kawakita D; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
Histopathology; 2022 Mar; 80(4):729-735. PubMed ID: 34657306
[TBL] [Abstract][Full Text] [Related]
16. Mucoepidermoid carcinoma of the esophagus with MAML2 gene rearrangement: Case report and literature review.
Chen R; Wang B; Li L; Xue L
Pathol Res Pract; 2023 Jan; 241():154242. PubMed ID: 36481651
[TBL] [Abstract][Full Text] [Related]
17. A clear cell variant of mucoepidermoid carcinoma harboring CRTC1-MAML2 fusion gene found in buccal mucosa: report of a case showing a large clear cell component and lacking typical epidermoid cells and intermediate cells.
Tajima S; Namiki I; Koda K
Med Mol Morphol; 2017 Jun; 50(2):117-121. PubMed ID: 26297211
[TBL] [Abstract][Full Text] [Related]
18. Primary mucoepidermoid carcinoma of the liver with CRTC1-MAML2 fusion: a case report.
Watanabe J; Kai K; Tanikawa K; Hiraki M; Mizukami N; Aishima S; Nakano T; Yamamoto H
Diagn Pathol; 2019 Jul; 14(1):84. PubMed ID: 31351495
[TBL] [Abstract][Full Text] [Related]
19. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands.
Martins C; Cavaco B; Tonon G; Kaye FJ; Soares J; Fonseca I
J Mol Diagn; 2004 Aug; 6(3):205-10. PubMed ID: 15269296
[TBL] [Abstract][Full Text] [Related]
20. HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status.
Nakano T; Yamamoto H; Hashimoto K; Tamiya S; Shiratsuchi H; Nakashima T; Nishiyama K; Higaki Y; Komune S; Oda Y
Histopathology; 2013 Sep; 63(3):378-92. PubMed ID: 23855785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
